News
12 Health Care Stocks Moving In Monday's Pre-Market Session
6 May 24
Movers
Allogene Therapeutics Awarded $15M Grant From California Institute For Regenerative Medicine To Advance Development Of Allogeneic CAR T In Renal Cell Carcinoma
26 Apr 24
News, Contracts
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
18 Apr 24
Long Ideas, Short Ideas, Trading Ideas, ETFs
HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Maintains $10 Price Target
19 Mar 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Reiterates Outperform on Allogene Therapeutics, Maintains $10 Price Target
15 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Allogene Therapeutics Q4 Earnings
14 Mar 24
Earnings
Allogene Therapeutics Q4 2023 GAAP EPS $(0.51) Misses $(0.46) Estimate, Sales $21.000K Miss $23.571K Estimate
14 Mar 24
Earnings, Earnings Misses, News
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
Allogene Therapeutics Earnings Preview
13 Mar 24
Earnings
Allogene Therapeutics And Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement To Support Advancement Of Next-Generation Allogeneic CAR T Platform In Autoimmune Disease
12 Mar 24
Biotech, News, General
JP Morgan Maintains Overweight on Allogene Therapeutics, Lowers Price Target to $8
27 Feb 24
News, Price Target, Analyst Ratings
Allogene Therapeutics To Restate Previously Filed Financial Statements Related To The December 2020 Formation Of The Allogene Overland Biopharm Joint Venture In Asia; No Impact On Cash, Cash Equivalents And Marketable Investments, Cash Runway Or Business Operations
16 Feb 24
News, Management
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
12 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Press releases
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
6 May 24
News, Press Releases
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
26 Apr 24
Press Releases
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
12 Mar 24
Press Releases
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
5 Mar 24
News, Press Releases
Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
28 Feb 24
News, Press Releases
Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
16 Feb 24
Press Releases